We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

DOJ Granted Leave To Join High Court Arguments Over Patent On-Sale Dates

Mealey's (October 10, 2018, 11:32 AM EDT) -- WASHINGTON, D.C. — The same day that Teva Pharmaceuticals USA Inc. filed its respondent brief in a U.S. Supreme Court dispute over what triggers the on-sale bar in the patent application...
To view the full article, register now.